Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
- Minor: SECURITY · Remote Monitoring Application in the Follow-up · Active Inflammatory Bowel Diseases Enrollment closed, study ongoing
- Notable: IB DYSPLASIA · Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study Recruitment opened
- Minor: TRENCH 1 · TRansmural hEaliNg Definition in CroHn's Disease Trial completed
- Minor: USTAP · USTekinumab in Fistulising Perianal Crohn's Disease Trial status changed: Unknown → Completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 4 | 4 |
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Crohn's Disease (5) · Ulcerative Colitis (5)
Get alerts when Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.